Alkem Laboratories Ltd. Vs.union of India and Anr.

Decided On : Nov-05-2019

Court : Delhi

LAW: Page 1, Section 26A of the Drugs and Cosmetics Act, Chapter, Section 26A of the Act, Page 3, Page 4, Section 26-A of the Drugs Act, Section 5, the Drugs Act, Section 26-A of the Drugs Act, Section 26-A of the Drugs Act, Page 9, Section 26A of the Act, Section 26A of the Act, Page 10 Pfizer Limited, Page 13, Rule 122B of the Rules, Article, Article, Article, Page 16

CARDINAL: 10.2019, 05, 1, 100, two, 796, 3, 52, 01.12.2016.6, 15.12.2017, 2, 344, 5, 349, 15, 17, 5, three, 1, one, three, 2, 6, 1, two, two, 8, one, three, two, 8, 12.02.2003, 18.10.2011, 20.03.2007, 35, 27, 19, 12, 1, two, two, two, 122E(c, two, 27, 14, NSAID.29, around 30,640, 46,070, two, 15, 12.02.2003, 48, DTAB.36, two, two, 17

MONEY: 10111/2018 & CM APPL

ORG: ALKEM LABORATORIES LTD, UNION OF INDIA, ANR, 41874/2018 & 41875/2018 M/S LEEFORD HEALTHCARE LTD, ANR, RESPONDENTS Chauhan, Adv, HORIZON BIOCEUTICALS PVT LTD + W.P.(C, 43810/2018 & 43811/2018, Adv, ZEE LABORATORIES LTD, 44090/2018 & 44091/2018, Adv, UNION OF INDIA, ANR, JUSTICE NAVIN CHAWLA1, FDC, Nimesulide + Diclofenac, no.1, the Central Government, Government, no.1, Expert Committee, Kokate Committee Report, Committee, the Experts Committee, Committee, Final Recommendations by Committee Name, FDC, FDC, Committee, FDC, NSAIDs, Court, WP, Court, the Supreme Court, the Supreme Court, Union of India, Pfizer Limited and Others, the Delhi High Court, the Kokate Committee Report, the Central Government, DTAB, the Central Government, the Kokate Committee, DTAB, DTAB, DTAB, the All-India Drugs Action Network, DTAB, DTAB, the Fixed Dose Combinations, FDC, DTAB, DTAB, DTAB, FDC, FDC, DTAB, the Central Government, DTAB, the Central Government, DTAB, the Drugs Technical Advisory Board, DTAB, DTAB, Gastrointestinal, NSAIDs, FDC, Drug Controller General of, FDC, the Non Steroidal-Inflammatory Drugs, NSAIDs, NSAIDs, the Supreme Court, Pfizer Limited and Others (Supra, DTAB/Sub-Committee, Page 7 FDC, DTAB, FDC, Simultaneous Estimation of Nimesulide and Diclofenac Sodium, Indian Journal of Pharmaceutical Sciences, Simultaneous Estimation of Nimesulide and Diclofenac Sodium, Combined Dosage Forms, (Asian Journal of Pharmaceutical Analysis, NSAIDs, Medical Chemistry Research, Meta-Analysis, The American Journal of Medicine, Diclofenac Sodium, Ibuprofen, Nimesulide, Post Operative Period of Surgical, Dental Sciences, FDC, FDC, Court, DTAB, DTAB, DTAB, the Supreme Court, Pfizer Limited, Court, DTAB, Court, V. Union of India, the Central Government, the Central Government, the Supreme Court, FDC, Unison Pharmaceuticals Pvt, Union of India, Court, Court, Court, Court, FDC, Court, The Sub- Committee, Pioglitazone 7.5, FDC, FDC, Emphasis, Lupin Limited, Anr., V. Union of India, Court, the Supreme Court, FDC, FDC, FDC, Sub-committee, Sub-committee, the Supreme Court, Pfizer Limited the Central Government, Subcommittee, M/s Microlabs Limited v., FDC, Court, DTAB, FDC, Gastrointestinal, NSAIDs, FDC, FDC, the Kokate Committee Report, DTAB, FDC, the Expert Committee, DTAB, FDC, a “New Drug, FDC, FDC, FDC, Court, DTAB, the Kokate Expert Committee, Nimesulide, the American Journal of Medicine, a Fixed Dose Combination, FDC, the Indian Journal of Pharmaceutical Sciences, Asian Journal of Pharmaceuticals Analysis, Simultaneous Estimation of Nimesulide and Diclofenac Sodium, Combined Dosage Forms, the Indian Journal of Pharmaceutical Sciences, Nimesulide and Diclofenac Sodium, FDC, the Journal of Evolution of Medical, Dental Sciences, Diclofenac Sodium, Ibuprofen, FDC, the Medicinal Chemistry Research, FDC, the Expert Committee, DTAB, FDC, DTAB, NSAIDs, FDC, Court

PERSON: Ishani Chandra, Shubhie Wahi, Kirtiman Singh, Ripu Daman Bhardwaj, Waize Ali Noor, Rohan Anand, Prateek Dhanda, T.P. Singh, Aditya, Kirtiman Singh, Ripu Daman Bhardwaj, Waize Ali Noor, Rohan Anand, Prateek Dhanda, T.P. Singh, Prabhat Kr, Chaurasia, Kirtiman Singh, Ripu Daman Bhardwaj, Waize Ali Noor, Rohan Anand, Prateek Dhanda, T.P. Singh, Siddhant Bambha, Kirtiman Singh, Ripu Daman Bhardwaj, Waize Ali Noor, Rohan Anand, Prateek Dhanda, T.P. Singh, Gazette, Xxxx 12, Pharmacodynami, Chandler S. Gautam, Lekha Saha, Br Clin, Kasarla Raju, Anr, Notifications, justification.33, Diclofenac, Appendix VI, Articles, Anr, Anr, Anr, Anr, Diclofenac, Diclofenac, Articles, Articles, Diclofenac, Diclofenac, Articles

DATE: 41873/2018, 11285/2018, 10751/2018, 11285/2018, 11399/2018, 07.09.2018, 1940, 10751/2018, 11285/2018, 11399/2018, 2 3, 10.03.2016, 4th to 9th January, 2016, 10751/2018, 11285/2018, 11399/2018, 2013, 2018, 10751/2018, 11285/2018, 11399/2018, pre-1988, 10751/2018, 11285/2018, 11399/2018, 5 7, a period of, six months, made:-"WP(C)10111/2018, 10751/2018,, 11285/2018, 11399/2018, below 12 years, 15 days, 10751/2018, 11285/2018, 11399/2018, 1945, 10751/2018, 11285/2018, 11399/2018, 01.02.2003, 2007, 10751/2018, 11285/2018, 11399/2018, 9739/2018, 10751/2018, 11285/2018, 11399/2018, 10403/2018, 10751/2018, 11285/2018, 11399/2018, 11 18, 10917/2018, 13.02.2019, 9978/2018, 10751/2018, 11285/2018, 11399/2018, below 12 years, 15 days, 22, the 1st, 10751/2018, 11285/2018, 11399/2018, years, years, 10751/2018, 11285/2018, 11399/2018, July, 2019, July, 2018, 10751/2018, 11285/2018, 11399/2018, 01.02.2003, 2011, 10751/2018, 11285/2018, 11399/2018, 2019, 10751/2018, 11285/2018, 11399/2018

PRODUCT: no.1, Notifications, no.1, Articles, Articles, Articles

WORK_OF_ART: 26A. Powers of Central Government

ORDINAL: first, First, third, 3rd, first, fourth

GPE: India, Nimesulide, DCGI, approved.12, WP, 08.01.2019, WP(C, India, WP(C, judgments.21, India, Nimesulide, Nimesulide, Nimesulide, Nimesulide, question.33, Nimesulide, question.34, Albino Wistar

NORP: Diclofenac, vultures).4, Diclofenac, vultures).4, Rules, Diclofenac

FAC: Wockhardt Limited, the Impugned Notification

LOC: question.31